MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We analyzed microRNA profile in hemolysis-free blood plasma of patients with prostatic cancer. The metastatic form of prostatic cancer was found to be associated with increased levels of hsa-miR-22-3p, hsa-miR-663a, and hsa-miR-4674 in comparison with non-metastatic form. Common candidate target genes of these microRNA include JUNB, KMT2A, and XPO6.

About the authors

E. N. Knyazev

BioClinicum Research and Development Center

Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow

T. R. Samatov

BioClinicum Research and Development Center

Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow

K. A. Fomicheva

National Medical Research Radiology Center

Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow

K. M. Nyushko

National Medical Research Radiology Center

Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow

B. Ya. Alekseev

National Medical Research Radiology Center

Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow

M. Yu. Shkurnikov

BioClinicum Research and Development Center; National Medical Research Radiology Center

Author for correspondence.
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow; Moscow


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies